
Opinion|Videos|October 18, 2024
Challenges in Adopting Novel Therapies
Key Takeaways
- Translating clinical trial results to diverse patient populations is a significant challenge in real-world settings.
- Complex treatment regimens necessitate specialized infrastructure and training for healthcare providers.
Panelists discuss how implementing novel combination therapies or emerging agents from clinical trials into real-world clinical practice for multiple myeloma faces significant challenges, including managing complex dosing regimens, addressing potential toxicities, ensuring patient adherence, navigating insurance coverage and cost issues, and bridging the gap between highly controlled trial conditions and diverse patient populations encountered in everyday clinical settings
Advertisement
Episodes in this series

Video content above is prompted by the following:
- What are the most significant challenges in implementing novel combination therapies or emerging agents from clinical trials into real-world clinical practice?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Early Recognition and Routine Discussion: Improving Outcomes in Tardive Dyskinesia
2
Targeting CSF1R in TGCT: Evaluating the Evidence and Empowering Pharmacist-Led Care
3
Meet the FDA’s Newly Approved OTC Sunscreen Ingredient: Bemotrizinol
4
Why Stanford, Harvard, and Yale Are Betting on Psychedelics
5










































































































